Dexcom (DXCM) Net Margin Growth (3y) (2013 - 2026)
Dexcom (DXCM) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 1,018.00 |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 399.00 |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 1,978.00 |
| 10 | Steris | 21.40 Bn | 20.96 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,018.00 |
| Dec 31, 2025 | 996.00 |
| Sep 30, 2025 | 1,032.00 |
| Jun 30, 2025 | 823.00 |
| Mar 31, 2025 | -530.00 |
| Dec 31, 2024 | 1,438.00 |
| Sep 30, 2024 | 11.00 |
| Jun 30, 2024 | 111.00 |
| Mar 31, 2024 | 471.00 |
| Dec 31, 2023 | -4,752.00 |
| Sep 30, 2023 | -203.00 |
| Jun 30, 2023 | 305.00 |
| Mar 31, 2023 | 164.00 |
| Dec 31, 2022 | -877.00 |
| Sep 30, 2022 | 159.00 |
| Jun 30, 2022 | 1,043.00 |
| Mar 31, 2022 | 2,506.00 |
| Dec 31, 2021 | 5,241.00 |
| Sep 30, 2021 | -405.00 |
| Jun 30, 2021 | 72.00 |